Why do microglial enhancement strategies show non-linear dose-response relationships in AD models?

OPEN

The debate noted that TREM2 loss-of-function increases AD risk, but questioned whether enhancement would be therapeutic due to potential non-linear relationships. The optimal level of microglial activation for therapeutic benefit remains undefined. Source: Debate session sess_SDA-2026-04-03-gap-seaad-v4-20260402065846 (Analysis: SDA-2026-04-03-gap-seaad-v4-20260402065846)

Priority: 0.75 Domain: immunology Hypotheses: 0

📊 Landscape Analysis

Landscape Summary: Why do microglial enhancement strategies show non-linear dose-response relationships in AD models? is a 0.75 priority gap in immunology. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Why do microglial enhancement strategies show non-linear dose-response relationships in AD models? — INVOKE-2 (completed)

📈 Living Dashboards

Hypotheses

0.000

Top Score

0.000

Avg Score

Debates

0.00

Avg Quality

Resolution

Mechanistic Families

Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

associated with (21)

entities-ros→ADentities-histone-methylation→ADentities-atp7b-gene→ADTAU→ADTDP-43→AD

▸ Show 16 more

APOE→ADMIR-146A→ADAD→TAUSOD1→ADSV2A→ADBnip3→ADtau N-terminal fragments→ADAPOE genotype→ADentities-dian-observational-study→ADentities-ltp→ADentities-neprilysin→ADT2D→ADMICROGLIA→ADAGE→ADPARK7→ADSNCA→AD

biomarker for (1)

tau cleavage products→AD

causes (6)

AD→neurodegenerationPHOSPHORYLATED_TAU→ADBETA_AMYLOID→ADAD→IMMUNE_TOLAD→memory_loss

▸ Show 1 more

AD→DEMENTIA

▸ Show 1 more

levetiracetam→AD

treats (1)

HTL9936→AD

🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions
Enrich with Semantic Scholar citations
Map to clinical trial endpoints

← Back to All Gaps

Why do microglial enhancement strategies show non-linear dose-response relationships in AD models?

Key Unanswered Questions

Key Researchers

Clinical Trials

Hypothesis Score Distribution

associated with (21)

biomarker for (1)

causes (6)

contributes to (1)

cross disease mechanism in (5)

depleted in (1)

prevents (1)

protective against (1)

regulates (1)

risk factor for (4)

targets (1)

therapeutic target for (6)

treats (1)